IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148 | +111.4% | 15,391 | +132.8% | 0.00% | – |
| Q2 2023 | $70 | +6900.0% | 6,612 | +5966.1% | 0.00% | – |
| Q1 2023 | $1 | -99.3% | 109 | -99.0% | 0.00% | – |
| Q4 2022 | $134 | -99.9% | 10,888 | -0.1% | 0.00% | – |
| Q2 2022 | $125,000 | +60.3% | 10,900 | +73.8% | 0.00% | – |
| Q1 2022 | $78,000 | +52.9% | 6,270 | +59.9% | 0.00% | – |
| Q3 2021 | $51,000 | -94.2% | 3,921 | -94.9% | 0.00% | -100.0% |
| Q4 2020 | $878,000 | +136.0% | 77,200 | +86.6% | 0.00% | 0.0% |
| Q3 2020 | $372,000 | +332.6% | 41,379 | +384.8% | 0.00% | – |
| Q1 2020 | $86,000 | +83.0% | 8,536 | +138.8% | 0.00% | – |
| Q4 2019 | $47,000 | +291.7% | 3,574 | +142.6% | 0.00% | – |
| Q3 2019 | $12,000 | – | 1,473 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |